Best Peptides for Testosterone

Testosterone is controlled by one chain of command: the hypothalamus releases GnRH, the pituitary answers with LH and FSH, and LH tells the testes to make testosterone. Only three compounds in this library act anywhere on that chain: hCG, gonadorelin and kisspeptin. Everything else sold in the same forums for "testosterone support", the GH-releasing peptides, works through a different receptor entirely and was never shown to touch it. This guide separates the two groups and ranks the HPG-axis compounds by what their own trials actually measured.

Summary

hCG: the only compound here that acts directly on the testes

Human chorionic gonadotropin is a glycoprotein hormone whose beta subunit is close enough to LH's that, in the words of its own US label, its action is virtually identical to that of pituitary LH. In men, that means it drives the Leydig cells of the testes to make testosterone without needing a signal from the pituitary at all. That is why it is approved for hypogonadotropic hypogonadism, a condition where the pituitary itself is not sending the LH signal. It bypasses gonadorelin and kisspeptin entirely, both of which depend on getting the pituitary or hypothalamus to respond first. hCG is also widely used off-label alongside testosterone therapy to keep the testes active, though that specific use is not a labelled indication in the products reviewed on its own page. hCG is an approved prescription medicine: prescribing belongs with a licensed Philippine physician, who can also order the bloodwork that shows whether it is doing anything.

Kisspeptin: the only human trial to measure testosterone directly from this group

Kisspeptin sits one step above gonadorelin in the chain: it stimulates the GnRH neurons themselves, rather than acting like GnRH at the pituitary. The clearest testosterone data anywhere in this guide comes from a 2005 trial by Dhillo and colleagues, which gave six healthy men a 90-minute intravenous infusion of kisspeptin-54 or saline in random order. Kisspeptin raised LH, FSH and testosterone above the saline infusion; mean LH over the 90 minutes was 10.8 U/L on kisspeptin against 4.2 U/L on saline. That is one small, single-dose trial. No study has tested repeated kisspeptin dosing over weeks to see whether testosterone stays elevated, and kisspeptin still depends on a working hypothalamus and pituitary to have any effect at all.

Gonadorelin: real regulatory history, but not for raising testosterone in men

Gonadorelin is a synthetic copy of GnRH itself, one step above hCG and one step below kisspeptin in the chain. It has a genuine approval history: Factrel (1982) tested pituitary function with a single dose and blood draws over two hours, and Lutrepulse (1989) induced ovulation in women through a pump delivering a small dose every 90 minutes, since GnRH only works when it arrives in pulses. Both US products are now discontinued. Gonadorelin is discussed in men's health circles as a way to keep the testes active during testosterone therapy, but no labelled indication or controlled trial supports that specific use, and the pulsatile-delivery requirement that made Lutrepulse work is a practical obstacle for a once or twice daily injection schedule. Any decision to use it belongs with a physician.

Why GH secretagogues do not belong in this ranking at all

Ipamorelin, CJC-1295, sermorelin, tesamorelin, GHRP-2, GHRP-6 and MK-677 are commonly stacked with testosterone therapy or marketed loosely as hormone support, but every human trial behind them measured growth hormone, IGF-1, sleep architecture, glucose or lean mass, never testosterone, LH or FSH. That is not an oversight: these compounds bind the ghrelin receptor or the GHRH receptor on pituitary somatotroph cells, a branch of the endocrine system that does not connect to the gonadotrope cells that release LH and FSH. Raising GH and IGF-1 has no established mechanism for raising testosterone. Anyone reading a claim that these peptides boost testosterone should ask which trial measured it, because none of the ones cited across this library did.

Reading a bloodwork panel before and after

Because hCG, gonadorelin and kisspeptin all claim to act on the same chain, the only way to see whether any of them changed anything is to measure it. LH, FSH and total testosterone are the three values the cited trials themselves tracked; a rise in one without the others is a reason to ask a physician what happened at that specific step of the chain, rather than assume the whole axis moved together. Bloodwork in the Philippines covers where these panels are available locally and what they cost. A GH-axis compound raising IGF-1 on the same panel is not evidence that testosterone changed too; the two markers sit on separate hormonal systems and one has never been shown to predict the other.

Status in the Philippines

hCG is a registered prescription medicine here; prescribing belongs with a licensed Philippine physician, the same rule that applies to any off-label use of gonadorelin a doctor might consider. No gonadorelin, kisspeptin or MK-677 product is registered with FDA Philippines for human use, and none is a controlled substance under RA 9165, so what circulates locally does so through research-peptide suppliers rather than pharmacies. For male athletes, the WADA Prohibited List bans both hCG and gonadorelin under section S2, at all times, precisely because of their effect on this axis; GH secretagogues such as GHRP-2 are banned separately, under the same section, for their effect on growth hormone rather than testosterone.